| Authors: |
Thoma G; Global Discovery Chemistry, Novartis Institutes for Biomedical Research, 4002 Basel, Switzerland., Decoret O; Global Discovery Chemistry, Novartis Institutes for Biomedical Research, 4002 Basel, Switzerland., Vangrevelinghe E; Global Discovery Chemistry, Novartis Institutes for Biomedical Research, 4002 Basel, Switzerland., Trunzer M; PK Sciences, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland., Decker A; Chemical and Pharmaceutical Profiling, Global Drug Development, Novartis Pharma AG, 4002 Basel, Switzerland., Orjuela Leon A; Immunology Disease Area, Novartis Institutes for Biomedical Research, 4002 Basel, Switzerland., Beerli C; Immunology Disease Area, Novartis Institutes for Biomedical Research, 4002 Basel, Switzerland., Bruno S; Immunology Disease Area, Novartis Institutes for Biomedical Research, 4002 Basel, Switzerland., Hauchard A; Immunology Disease Area, Novartis Institutes for Biomedical Research, 4002 Basel, Switzerland., Paulat G; Immunology Disease Area, Novartis Institutes for Biomedical Research, 4002 Basel, Switzerland., Zerwes HG; Immunology Disease Area, Novartis Institutes for Biomedical Research, 4002 Basel, Switzerland., Hacini-Rachinel F; Immunology Disease Area, Novartis Institutes for Biomedical Research, 4002 Basel, Switzerland. |